Effect of roxadustat on iron metabolism in patients with peritoneal dialysis: a real-world 24-week study

Abstract Background Roxadustat is an oral hypoxia inducing factor-prolyl hydroxylase inhibitor (HIF-PHI) that regulates iron metabolism in patients with chronic kidney disease (CKD) primarily by reducing hepcidin levels and mobilizing internal iron stores. More data are needed to demonstrate the eff...

Description complète

Détails bibliographiques

Auteurs principaux:	Xuejie Zhang, Ruoyu Jia, Zhifang Zheng, Luhua Jiang, Yizhou Xu, Ashok Raj, Dong Sun
Format:	Artigo
Langue:	Inglês
Publié:	BMC 2023-11-01
Collection:	European Journal of Medical Research
Sujets:	Peritoneal dialysis (PD) Anemia Hypoxia inducible factor-prolyl hydroxylase inhibitors (HIF-PHI) Iron metabolism
Accès en ligne:	https://doi.org/10.1186/s40001-023-01465-0
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!